Supraventricular tachycardia AHA recommendations for Management of IST: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| (6 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{AA}} | {{CMG}} {{AE}}{{AA}} | ||
==Overview== | ==Overview== | ||
Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. Ivabradine is reasonable for ongoing management in patients with symptomatic IST.<ref name="pmid26409259">{{cite journal| author=Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al.| title=2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2016 | volume= 67 | issue= 13 | pages= e27-e115 | pmid=26409259 | doi=10.1016/j.jacc.2015.08.856 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26409259 }} </ref> | |||
2015 AHA | |||
== | ==Management of IST(Inappropriate sinus tachycardia)== | ||
2015 AHA recommendations for management of IST are described below:<ref name="pmid26409259">{{cite journal| author=Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al.| title=2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2016 | volume= 67 | issue= 13 | pages= e27-e115 | pmid=26409259 | doi=10.1016/j.jacc.2015.08.856 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26409259 }} </ref> | |||
===Acute treatment of IST ([[Inappropriate sinus tachycardia]])=== | |||
=== | There are no specific recommendations for acute treatment of IST. | ||
===Treatment of ongoing IST === | |||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
Latest revision as of 15:39, 27 October 2016
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of IST On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of IST |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of IST |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of IST |
|
Supraventricular tachycardia AHA recommendations for Management of IST in the news |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of IST |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. Ivabradine is reasonable for ongoing management in patients with symptomatic IST.[1]
Management of IST(Inappropriate sinus tachycardia)
2015 AHA recommendations for management of IST are described below:[1]
Acute treatment of IST (Inappropriate sinus tachycardia)
There are no specific recommendations for acute treatment of IST.
Treatment of ongoing IST
| Class I |
| "1.Evaluation for and treatment of reversible causes are recommended in patients with suspected IST "(Level of Evidence: C-LD) " |
| Class IIa |
| "1.Ivabradine is reasonable for ongoing management in patients with symptomatic IST "(Level of Evidence: B-R) " |
| Class IIb |
| "1.Beta blockers may be considered for ongoing management in patients with symptomatic IST "(Level of Evidence:C-LD) " |
| "2.The combination of beta blockers and ivabradine may be considered for ongoing management in patients with IST ( "(Level of Evidence: C-LD) " |
References
- ↑ 1.0 1.1 Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.